ã·ãŒ ã¹ã±ãŒã ããŒã ãªãŸãŒãã¯ãå®¶æé£ãã«åªãããåºã
ãšãããªãŸãŒãããæ¢ãã®æ¹ã«æé©ãªéžæè¢ã§ãããã®ãªãŸãŒãã¯ããªãŒã·ã£ã³ãã¥ãŒã®çŸããæ·å°ãç¹åŸŽã§ãå®¶æãã°ã«ãŒãã«æé©ãªãŽã£ã©ããããŸããããŒã«ã¯ãã€ã©ã€ãã§ã3ã€ã®ããŒã«ãšãããã¿ããæž©æ°ŽããŒã«ã倧人å°çšããŒã«ãå®¶æåãããŒã«ã®ãªãã·ã§ã³ããæ¥œãã¿ããã ããŸãããã ããCOVID-19ã®å¶éã«ãããããŒã«ã®æéãäºçŽããå¿
èŠããããããŒã«ã®å©çšãå¶éãããŸããããŒã«ã«è¡ãã®ã«å°ãæ©ããªããã°ãªããªãã²ã¹ããããŸããããããŒãã«è¿ãããšããããè£ã£ãŠããŸãããæ®å¿µãªãããããŒã«ããŒãæ¥é°ãã¿ãªã«ãµãŒãã¹ãªã©ã®ã¢ã¡ããã£ã¯ãããŸãããããã€ãã®å¶éã¯ãããŸãããã²ã¹ãã¯æž©æ°ŽããŒã«ãšãžã£ã°ãžãŒãå§åçã«æ¥œããã§ãããæž©åºŠã¯åžžã«å®ç§ã§ãããå
šäœãšããŠãã·ãŒ ã¹ã±ãŒã ããŒã ãªãŸãŒãã¯ããªã©ãã¯ã¹ããŠæ¥œããå®¶ææ
è¡ããæ¢ãã®æ¹ã«æé©ãªéžæè¢ã§ãã